NO974793L - Fremgangsmåte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav - Google Patents

Fremgangsmåte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav

Info

Publication number
NO974793L
NO974793L NO974793A NO974793A NO974793L NO 974793 L NO974793 L NO 974793L NO 974793 A NO974793 A NO 974793A NO 974793 A NO974793 A NO 974793A NO 974793 L NO974793 L NO 974793L
Authority
NO
Norway
Prior art keywords
oncostatin
onkostatin
fragment
preparing
monoclonal antibody
Prior art date
Application number
NO974793A
Other languages
English (en)
Other versions
NO305867B1 (no
NO974793D0 (no
Inventor
Susan F Radka
Peter S Linsley
Mohammed Shoyab
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO974793L publication Critical patent/NO974793L/no
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO974793D0 publication Critical patent/NO974793D0/no
Publication of NO305867B1 publication Critical patent/NO305867B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO974793A 1990-03-29 1997-10-17 FremgangsmÕte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav NO305867B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50182490A 1990-03-29 1990-03-29
US66419191A 1991-03-04 1991-03-04

Publications (3)

Publication Number Publication Date
NO974793L true NO974793L (no) 1991-09-30
NO974793D0 NO974793D0 (no) 1997-10-17
NO305867B1 NO305867B1 (no) 1999-08-09

Family

ID=27053942

Family Applications (2)

Application Number Title Priority Date Filing Date
NO911127A NO303226B1 (no) 1990-03-29 1991-03-21 Monoklonalt antistoff mot Onkostatin M, samt DNA-molekyl, cellelinje og hybridom
NO974793A NO305867B1 (no) 1990-03-29 1997-10-17 FremgangsmÕte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO911127A NO303226B1 (no) 1990-03-29 1991-03-21 Monoklonalt antistoff mot Onkostatin M, samt DNA-molekyl, cellelinje og hybridom

Country Status (17)

Country Link
EP (1) EP0451612B1 (no)
JP (1) JPH05244980A (no)
KR (1) KR910016345A (no)
AT (1) ATE147106T1 (no)
AU (1) AU649658B2 (no)
CA (1) CA2039231A1 (no)
DE (1) DE69123871T2 (no)
DK (1) DK0451612T3 (no)
ES (1) ES2097160T3 (no)
GR (1) GR3022222T3 (no)
HU (1) HUT62039A (no)
IE (1) IE911078A1 (no)
IL (1) IL97623A (no)
NO (2) NO303226B1 (no)
NZ (1) NZ237533A (no)
OA (1) OA09745A (no)
PT (1) PT97179B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
WO2001036472A2 (en) * 1999-11-16 2001-05-25 The General Hospital Corporation Compositions and methods for regulating tumor-associated antigen expression
BR112013009083B1 (pt) 2010-10-13 2021-08-10 Janssen Biotech, Inc. Anticorpos humanos para oncostatina m, seu processo de fabricação, fragmento de ligação a antígeno, composição farmacêutica, polinucleotídeo isolado, célula hospedeira recombinante estavelmente transformada ou transfectada
US20170327573A1 (en) * 2014-09-24 2017-11-16 Universitá Degli Studi Di Padova Composition to induce bone marrow stem cell mobilization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
NZ237533A (en) 1992-12-23
AU649658B2 (en) 1994-06-02
PT97179B (pt) 1998-07-31
ATE147106T1 (de) 1997-01-15
EP0451612B1 (en) 1997-01-02
AU7390891A (en) 1991-11-07
ES2097160T3 (es) 1997-04-01
DE69123871D1 (de) 1997-02-13
DK0451612T3 (da) 1997-06-16
DE69123871T2 (de) 1997-08-14
NO911127L (no) 1991-09-30
NO303226B1 (no) 1998-06-15
NO305867B1 (no) 1999-08-09
IL97623A (en) 1996-01-19
OA09745A (en) 1993-11-30
GR3022222T3 (en) 1997-04-30
PT97179A (pt) 1991-11-29
NO911127D0 (no) 1991-03-21
NO974793D0 (no) 1997-10-17
HUT62039A (en) 1993-03-29
EP0451612A1 (en) 1991-10-16
KR910016345A (ko) 1991-11-05
JPH05244980A (ja) 1993-09-24
HU911006D0 (en) 1991-10-28
IE911078A1 (en) 1991-10-09
CA2039231A1 (en) 1991-09-30

Similar Documents

Publication Publication Date Title
FI100973B (fi) Menetelmä antigeenirakenteiden valmistamiseksi "Major Histocompatibili ty Complex" (MHC) luokka I -antigeeneistä ja monoklonaalisista vasta-a ineista
DE59010787D1 (de) Erythropoietin (EPO)-Peptide und dagegen gerichtete Antikörper
DE69016401D1 (de) Optischer Sensor zur Bestimmung der Zusammensetzung von Brennstoff.
EP0521996A4 (en) Catalytic antibody components
FI950378A (fi) Immuunitesti kollageenin tai kollageenifragmenttien havaitsemiseksi
PT99676A (pt) Processo de preparacao de um polipeptido e de determinacao da presenca de auto-anticorpos anti-gpiiia
NO974793D0 (no) Fremgangsmåte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav
HK1021228A1 (en) In vitro method for determining the presence of hepatocellular carcinoma
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
DE59208543D1 (de) Künstliche Standard- und Kontrollseren zur Verwendung in Verfahren zur Bestimmung von Antikörpern
DE58907208D1 (de) Verfahren zur Bestimmung von Antikörpern.
DE58904518D1 (de) Verfahren zur bildlichen darstellung von tumoren unter verwendung von monoklonalen antikoerpern.
NO900092L (no) Et ekspresjonssystem for fremstilling av kimeriske monoklonale antistoffer.
NO912192L (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
NO960274L (no) Fremgangsmåte for fremstilling av antistoff eller fragment derav
ATE89749T1 (de) Verfahren zur bildlichen darstellung von tumoren unter verwendung von monoklonalen antikoerpern.
NO180637C (no) Fremgangsmåte for fremstilling av monoklonale antistoffer eller fragmenter derav
ATE103073T1 (de) Verfahren zur bestimmung von antikoerpern.

Legal Events

Date Code Title Description
MK1K Patent expired